Depixus is undertaking commercial development of a technology for the fast, accurate, and inexpensive extraction of genetic and epigenetic information from single molecules of DNA and RNA.
The technology is known as SIMDEQ™ (SIngle-molecule Magnetic DEtection and Quantification). It was initially developed at École Normale Supérieure (ENS), one of France's leading 'grandes écoles'.
SIMDEQ™ has a wide range of potential applications across the life-science and medical industries.
Using the SIMDEQ™ platform, it will be possible to identify, count, fully sequence, and epitype many millions of individual molecules of DNA at a high speed and accuracy.
Substantial validation of our technology has already been completed and the first steps towards platform optimisation and commercialisation are currently underway.